DIMA Biotechnology BCMA antibody

Anti-BCMA antibody(DM3), Rabbit mAb
DIMA Biotechnology
catalog: DME100003

domestic rabbit monoclonal (DM3)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. A. Flow cytometry analysis with anti-BCMA (DM3) on NCI-H929 cells (Red histogram) or rabbit control antibody on NCI-H929 cells (Blue histogram). B. Flow cytometry data of serially titrated anti-BCMA (DM3) on NCI-H929 cells. The Y-axis represents the mean fluorescence intensity (MFI) while the X-axis represents the concentration of IgG used.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3. DM3 clone exhibits the strongest inhibition (Red bar). This data indicated that DM3 bind to the same epitope as bb2121.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM2), Rabbit mAb
DIMA Biotechnology
catalog: DME100002

domestic rabbit monoclonal (DM2)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. A. Flow cytometry analysis with anti-BCMA (DM2) on NCI-H929 cells (Red histogram) or rabbit control antibody on NCI-H929 cells (Blue histogram). B. Flow cytometry data of serially titrated anti-BCMA (DM2) on NCI-H929 cells. The Y-axis represents the mean fluorescence intensity (MFI) while the X-axis represents the concentration of IgG used.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3. DM3 clone exhibits the strongest inhibition (Red bar). This data indicated that DM3 bind to the same epitope as bb2121.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM4), Rabbit mAb
DIMA Biotechnology
catalog: DME100004

domestic rabbit monoclonal (DM4)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. A. Flow cytometry analysis with anti-BCMA (DM4) on NCI-H929 cells (Red histogram) or rabbit control antibody on NCI-H929 cells (Blue histogram). B. Flow cytometry data of serially titrated anti-BCMA (DM4) on NCI-H929 cells. The Y-axis represents the mean fluorescence intensity (MFI) while the X-axis represents the concentration of IgG used.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3. DM3 clone exhibits the strongest inhibition (Red bar). This data indicated that DM3 bind to the same epitope as bb2121.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM5), Rabbit mAb
DIMA Biotechnology
catalog: DME100005

domestic rabbit monoclonal (DM5)
reactivity: human
application: flow cytometry

Figure 1. A. Flow cytometry analysis with anti-BCMA (DM5) on NCI-H929 cells (Red histogram) or rabbit control antibody on NCI-H929 cells (Blue histogram). B. Flow cytometry data of serially titrated anti-BCMA (DM5) on NCI-H929 cells. The Y-axis represents the mean fluorescence intensity (MFI) while the X-axis represents the concentration of IgG used.

Figure 2. A. Flow cytometry analysis with anti-BCMA (DM5) on NCI-H929 cells (Red histogram) or rabbit control antibody on NCI-H929 cells (Blue histogram). B. Flow cytometry data of serially titrated anti-BCMA (DM5) on NCI-H929 cells. The Y-axis represents the mean fluorescence intensity (MFI) while the X-axis represents the concentration of IgG used.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3. DM3 clone exhibits the strongest inhibition (Red bar). This data indicated that DM3 bind to the same epitope as bb2121.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM6), Rabbit mAb
DIMA Biotechnology
catalog: DME100006

domestic rabbit monoclonal (DM6)
reactivity: human
application: flow cytometry

Figure 1. A. Flow cytometry analysis with anti-BCMA (DM6) on NCI-H929 cells (Red histogram) or rabbit control antibody on NCI-H929 cells (Blue histogram). B. Flow cytometry data of serially titrated anti-BCMA (DM6) on NCI-H929 cells. The Y-axis represents the mean fluorescence intensity (MFI) while the X-axis represents the concentration of IgG used.

Figure 2. A. Flow cytometry analysis with anti-BCMA (DM6) on NCI-H929 cells (Red histogram) or rabbit control antibody on NCI-H929 cells (Blue histogram). B. Flow cytometry data of serially titrated anti-BCMA (DM6) on NCI-H929 cells. The Y-axis represents the mean fluorescence intensity (MFI) while the X-axis represents the concentration of IgG used.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3. DM3 clone exhibits the strongest inhibition (Red bar). This data indicated that DM3 bind to the same epitope as bb2121.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM7), Rabbit mAb
DIMA Biotechnology
catalog: DME100007

domestic rabbit monoclonal (DM7)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. A. Flow cytometry analysis with anti-BCMA (DM7) on NCI-H929 cells (Red histogram) or rabbit control antibody on NCI-H929 cells (Blue histogram). B. Flow cytometry data of serially titrated anti-BCMA (DM7) on NCI-H929 cells. The Y-axis represents the mean fluorescence intensity (MFI) while the X-axis represents the concentration of IgG used.

Figure 2. A. Flow cytometry analysis with anti-BCMA (DM7) on NCI-H929 cells (Red histogram) or rabbit control antibody on NCI-H929 cells (Blue histogram). B. Flow cytometry data of serially titrated anti-BCMA (DM7) on NCI-H929 cells. The Y-axis represents the mean fluorescence intensity (MFI) while the X-axis represents the concentration of IgG used.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3. DM3 clone exhibits the strongest inhibition (Red bar). This data indicated that DM3 bind to the same epitope as bb2121.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM2)
DIMA Biotechnology
catalog: DMB100001

domestic rabbit monoclonal (DM2)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM2 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM2 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM3)
DIMA Biotechnology
catalog: DMB100002

domestic rabbit monoclonal (DM3)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM3 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM3 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM4)
DIMA Biotechnology
catalog: DMB100003

domestic rabbit monoclonal (DM4)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM4 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM4 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM5)
DIMA Biotechnology
catalog: DMB100004

domestic rabbit monoclonal (DM5)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM5 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM5 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM16)
DIMA Biotechnology
catalog: DMB100005

domestic rabbit monoclonal (DM16)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM16 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM16 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM17)
DIMA Biotechnology
catalog: DMB100006

domestic rabbit monoclonal (DM17)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM17 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM17 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM18)
DIMA Biotechnology
catalog: DMB100007

domestic rabbit monoclonal (DM18)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM18 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM18 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM19)
DIMA Biotechnology
catalog: DMB100008

domestic rabbit monoclonal (DM19)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM19 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM19 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM20)
DIMA Biotechnology
catalog: DMB100009

domestic rabbit monoclonal (DM20)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM20 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM20 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA bispecific antibody(DM21)
DIMA Biotechnology
catalog: DMB100010

domestic rabbit monoclonal (DM21)
reactivity: human
application: flow cytometry

Figure 1. The basic principle of BiTE cell killing assay. The BiTE molecule can effectively bring T cells to tumor target cells and stimulate tumor cell killing activity of T cells.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM21 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.

Figure 2. A: The scheme of Anti-BCMA BiTE molecule. B: Tumor cell killing assay. NCI-H929 cells (stably transfected with luciferase), were incubated with freshly isolated human PBMC, and different concentration of BiTE antibodies constructed from rabbit Anti-Human BCMA/TNFRSF17 Clone DM21 (red line), or BB2121 originated huC11D5.3 clone (blue line) or a no BCMA binding clone as negative control (black line). After 48hrs incubation, the viable NCI-H929 tumor cells were measured by luciferase activity assay.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM15), Rabbit mAb
DIMA Biotechnology
catalog: DME100019

domestic rabbit monoclonal (DM15)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. Detection of BCMA/ TNFRSF 17 in K562-BCMA (K562 cells transduced with gene for full length BCMA) Human Cell Line or NCI-H929 Human Cell Line with Rabbit Anti-Human BCMA/TNFRSF 17 Antigen Affinity-purified monoclonal antibody (clone: DM15) by Flow Cytometry.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM16), Rabbit mAb
DIMA Biotechnology
catalog: DME100020

domestic rabbit monoclonal (DM16)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. Detection of BCMA/ TNFRSF 17 in K562-BCMA (K562 cells transduced with gene for full length BCMA) Human Cell Line or NCI-H929 Human Cell Line with Rabbit Anti-Human BCMA/TNFRSF 17 Antigen Affinity-purified monoclonal antibody (clone: DM16) by Flow Cytometry.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM17), Rabbit mAb
DIMA Biotechnology
catalog: DME100021

domestic rabbit monoclonal (DM17)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. Detection of BCMA/ TNFRSF 17 in K562-BCMA (K562 cells transduced with gene for full length BCMA) Human Cell Line or NCI-H929 Human Cell Line with Rabbit Anti-Human BCMA/TNFRSF 17 Antigen Affinity-purified monoclonal antibody (clone: DM17) by Flow Cytometry.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM18), Rabbit mAb
DIMA Biotechnology
catalog: DME100022

domestic rabbit monoclonal (DM18)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. Detection of BCMA/ TNFRSF 17 in K562-BCMA (K562 cells transduced with gene for full length BCMA) Human Cell Line or NCI-H929 Human Cell Line with Rabbit Anti-Human BCMA/TNFRSF 17 Antigen Affinity-purified monoclonal antibody (clone: DM15) by Flow Cytometry.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM19), Rabbit mAb
DIMA Biotechnology
catalog: DME100023

domestic rabbit monoclonal (DM19)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. Detection of BCMA/ TNFRSF 17 in K562-BCMA (K562 cells transduced with gene for full length BCMA) Human Cell Line or NCI-H929 Human Cell Line with Rabbit Anti-Human BCMA/TNFRSF 17 Antigen Affinity-purified monoclonal antibody (clone: DM19) by Flow Cytometry.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA antibody(DM20), Rabbit mAb
DIMA Biotechnology
catalog: DME100024

domestic rabbit monoclonal (DM20)
reactivity: human
application: immunoprecipitation, flow cytometry

Figure 1. Detection of BCMA/ TNFRSF 17 in K562-BCMA (K562 cells transduced with gene for full length BCMA) Human Cell Line or NCI-H929 Human Cell Line with Rabbit Anti-Human BCMA/TNFRSF 17 Antigen Affinity-purified monoclonal antibody (clone: DM20) by Flow Cytometry.

Figure 2. ELISA plate was coated with recombinant BCMA-hFc fusion protein (PME100001), followed by pre-blocking with huC11D5.3 antibody (Grey bar) or rabbit control IgG (Black bar), and then different rabbit DimAbs antibodies were added to check the competitive inhibition of huC11D5.3.
quantity: 10 μl, 100 μl
price: 60 USD, 398 USD
to the supplier

Anti-BCMA mAb
DIMA Biotechnology
catalog: BME100016

human monoclonal (BME100016)
reactivity: human
application: ELISA

quantity: 50 μl, 100 μl
price: 80 USD, 160 USD
to the supplier